- Report
- March 2024
- 190 Pages
Global
From €3259EUR$3,374USD£2,789GBP
€3621EUR$3,749USD£3,099GBP
- Report
- January 2024
- 193 Pages
Global
From €5747EUR$5,950USD£4,918GBP
- Report
- March 2024
- 200 Pages
Global
From €4008EUR$4,150USD£3,430GBP
- Report
- January 2024
- 278 Pages
Global
€4824EUR$4,995USD£4,128GBP
- Report
- September 2023
- 105 Pages
United States
From €5747EUR$5,950USD£4,918GBP
- Report
- November 2023
- 178 Pages
Global
From €4732EUR$4,900USD£4,050GBP
- Report
- July 2023
- 163 Pages
Global
From €2415EUR$2,500USD£2,066GBP
The Oral Solid Dosage Contract Manufacturing market is a subset of the Pharmaceutical Manufacturing industry. It involves the production of oral solid dosage forms, such as tablets, capsules, and powders, for pharmaceutical companies. This type of manufacturing is often outsourced to contract manufacturers, who specialize in the production of these products. Contract manufacturers provide a range of services, including formulation development, process optimization, and quality control. They also provide packaging and labeling services, as well as regulatory support. This type of manufacturing is highly regulated, and contract manufacturers must adhere to strict quality standards.
Some companies in the Oral Solid Dosage Contract Manufacturing market include Patheon, Recipharm, Catalent, and Aenova. Show Less Read more